Skip to main content

Peer Review reports

From: Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

Original Submission
18 Feb 2020 Submitted Original manuscript
19 Feb 2020 Reviewed Reviewer Report - Kirsty Loudon
21 Feb 2020 Reviewed Reviewer Report - Susan Ellenberg
21 Feb 2020 Reviewed Reviewer Report - Lee Middleton
24 Feb 2020 Reviewed Reviewer Report - Karla Hemming
24 Feb 2020 Reviewed Reviewer Report - Susan Mallett
24 Feb 2020 Reviewed Reviewer Report - Nigel Stallard
24 Feb 2020 Reviewed Reviewer Report - Andrew Copas
26 Feb 2020 Reviewed Reviewer Report - Michael Grayling
27 Feb 2020 Reviewed Reviewer Report - Charles Weijer
12 Apr 2020 Author responded Author comments - Peter Horby
Resubmission - Version 2
12 Apr 2020 Submitted Manuscript version 2
Publishing
27 Apr 2020 Editorially accepted
24 May 2020 Article published 10.1186/s13063-020-04352-9

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215